Cargando…
A novel view on an old drug, 5-fluorouracil: an unexpected RNA modifier with intriguing impact on cancer cell fate
5-Fluorouracil (5-FU) is a chemotherapeutic drug widely used to treat patients with solid tumours, such as colorectal and pancreatic cancers. Colorectal cancer (CRC) is the second leading cause of cancer-related death and half of patients experience tumour recurrence. Used for over 60 years, 5-FU wa...
Autores principales: | Chalabi-Dchar, Mounira, Fenouil, Tanguy, Machon, Christelle, Vincent, Anne, Catez, Frédéric, Marcel, Virginie, Mertani, Hichem C, Saurin, Jean-Christophe, Bouvet, Philippe, Guitton, Jérôme, Venezia, Nicole Dalla, Diaz, Jean-Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364333/ https://www.ncbi.nlm.nih.gov/pubmed/34409299 http://dx.doi.org/10.1093/narcan/zcab032 |
Ejemplares similares
-
Ribosome Biogenesis Alterations in Colorectal Cancer
por: Nait Slimane, Sophie, et al.
Publicado: (2020) -
Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance
por: Therizols, Gabriel, et al.
Publicado: (2022) -
Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation
por: Chalabi-Dchar, Mounira, et al.
Publicado: (2021) -
Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method
por: Machon, Christelle, et al.
Publicado: (2021) -
Translational reprogramming of colorectal cancer cells induced by 5-fluorouracil through a miRNA-dependent mechanism
por: Bash-Imam, Zeina, et al.
Publicado: (2017)